now you see the damage inflicted on shareholders when mgmt's interests are to line their pockets with cheap options which they obtained by selling the company off for pennies on the dollar of development costs. now you know why the BOD consists of three incestuous insiders with zero biotech experience.
Market Data 
Markets 
AI
